Teresa L. Young

Teresa L. Young is a declared insider of Seres Therapeutics, Inc., with filings sourced from SEC (Form 4). We count 12 filings; the first trade dates from 27 October 2023 and the latest from 15 February 2026.

Not one of the filings records a straightforward purchase or sale on the market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.

The latest filing, published on 18 February 2026, reports an option exercise in Seres Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.